Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul S Changelian

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Trends in Molecular Medicine|November 3, 2004
JAK3 inhibition, a viable new modality of immunosuppression for solid organ transplantsDominic C Borie, John J O'Shea, Paul S Changelian
Current Opinion in Investigational Drugs (London, England : 2000)|February 5, 2004
JAK3 inhibition as a new concept for immune suppressionDominic C Borie, Ming-Sing Si, Randall E Morris, et al.
Therapeutic Drug Monitoring|September 22, 2005
Quantitative analysis of the immunosuppressant CP-690,550 in whole blood by column-switching high-performance liquid chromatography and mass spectrometry detectionRicardo Paniagua, Andrew Campbell, Paul S Changelian, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 8, 2020
Translating JAKs to JakinibsMassimo Gadina, Danielle A Chisolm, Rachael L Philips, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 16, 2010
Ecto-5'-nucleotidase (CD73) attenuates allograft airway rejection through adenosine 2A receptor stimulationTakashi Ohtsuka, Paul S Changelian, Diane Bouïs, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 4, 2006
Janus kinase 3 inhibition with CP-690,550 prevents allograft vasculopathyGeraldine Rousvoal, Ming-Sing Si, Macy Lau, et al.
Iscience|December 1, 2021
Cross-species transcriptomic signatures predict response to MK2 inhibition in mouse models of chronic inflammationLucia Suarez-Lopez, Bing Shui, Douglas K Brubaker, et al.
Transplantation|November 30, 2005
Effects of JAK3 inhibition with CP-690,550 on immune cell populations and their functions in nonhuman primate recipients of kidney allograftsRicardo Paniagua, Ming-Sing Si, Mona G Flores, et al.
Transplantation|December 27, 2005
Combined use of the JAK3 inhibitor CP-690,550 with mycophenolate mofetil to prevent kidney allograft rejection in nonhuman primatesDominic C Borie, Michael J Larson, Mona G Flores, et al.
Blood|December 21, 2007
The specificity of JAK3 kinase inhibitorsPaul S Changelian, Deborah Moshinsky, Cyrille F Kuhn, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Trends in Molecular Medicine|November 3, 2004
JAK3 inhibition, a viable new modality of immunosuppression for solid organ transplantsDominic C Borie, John J O'Shea, Paul S Changelian
Current Opinion in Investigational Drugs (London, England : 2000)|February 5, 2004
JAK3 inhibition as a new concept for immune suppressionDominic C Borie, Ming-Sing Si, Randall E Morris, et al.
Therapeutic Drug Monitoring|September 22, 2005
Quantitative analysis of the immunosuppressant CP-690,550 in whole blood by column-switching high-performance liquid chromatography and mass spectrometry detectionRicardo Paniagua, Andrew Campbell, Paul S Changelian, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 8, 2020
Translating JAKs to JakinibsMassimo Gadina, Danielle A Chisolm, Rachael L Philips, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 16, 2010
Ecto-5'-nucleotidase (CD73) attenuates allograft airway rejection through adenosine 2A receptor stimulationTakashi Ohtsuka, Paul S Changelian, Diane Bouïs, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 4, 2006
Janus kinase 3 inhibition with CP-690,550 prevents allograft vasculopathyGeraldine Rousvoal, Ming-Sing Si, Macy Lau, et al.
Iscience|December 1, 2021
Cross-species transcriptomic signatures predict response to MK2 inhibition in mouse models of chronic inflammationLucia Suarez-Lopez, Bing Shui, Douglas K Brubaker, et al.
Transplantation|November 30, 2005
Effects of JAK3 inhibition with CP-690,550 on immune cell populations and their functions in nonhuman primate recipients of kidney allograftsRicardo Paniagua, Ming-Sing Si, Mona G Flores, et al.
Transplantation|December 27, 2005
Combined use of the JAK3 inhibitor CP-690,550 with mycophenolate mofetil to prevent kidney allograft rejection in nonhuman primatesDominic C Borie, Michael J Larson, Mona G Flores, et al.
Blood|December 21, 2007
The specificity of JAK3 kinase inhibitorsPaul S Changelian, Deborah Moshinsky, Cyrille F Kuhn, et al.
Pageof 2